Enguent Jean-Pierre
- SEC CIK
- 0002114888
In the past year, 6 open-market sale filings worth $247.7K and no purchases.
Current role at each company
- LAES SEALSQ CorpVice President, R&DSSas of Sep 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $247.7K
- 6 filings
- Net
- −$247.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Enguent Jean-Pierre as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 (view filing)4:40 PM ET | Sep 3 | Same day | Enguent Jean-PierreVice President, R&DSS | SSale | −15.0K | $2.40 | −$36.0K | −100.0%0 after | 10b5-1 |
| Aug 5, 2026 (view filing)6:20 PM ET | Aug 5 | Same day | Enguent Jean-PierreVice President, R&DSS | SSale | −15.0K | $2.46 | −$36.9K | −100.0%0 after | 10b5-1 |
| Jul 8, 2026 (view filing)4:50 PM ET | Jul 8 | Same day | Enguent Jean-PierreVice President, R&DSS | SSale | −15.0K | $2.82 | −$42.3K | −100.0%0 after | 10b5-1 |
| Jun 3, 2026 (view filing)5:15 PM ET | Jun 3 | Same day | Enguent Jean-PierreVice President, R&DSS | SSale | −15.0K | $3.51 | −$52.7K | −100.0%0 after | 10b5-1 |
| May 7, 2026 (view filing) | May 6 | 1 day | Enguent Jean-PierreVice President, R&DSS | SSale | −15.0K | $3.13 | −$47.0K | −100.0%0 after | 10b5-1 |
| Apr 9, 2026 (view filing)4:15 PM ET | Apr 8 | 1 day | Enguent Jean-PierreVice President, R&DSS | SSale | −15.0K | $2.20 | −$33.0K | −100.0%0 after | 10b5-1 |